Loading...
Loading...
India's clindamycin imports from UNITED STATES total $150.0K across 64 shipments from 15 foreign suppliers. ZYDUS HEALTHCARE (USA) LLC leads with $50.5K in import value; the top 5 suppliers together control 73.9% of this origin. Leading Indian buyers include ZYDUS LIFESCIENCES LIMITED. This corridor reflects India's pharmaceutical import demand for clindamycin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

ZYDUS HEALTHCARE (USA) LLC is the leading Clindamycin supplier from UNITED STATES to India, with import value of $50.5K across 3 shipments. The top 5 suppliers — ZYDUS HEALTHCARE (USA) LLC, SSS PHARMACY INC, NEWLIFE MEDICALS (USA). INC., AGRACE PHARMA, AGRACE PHARMA, — collectively account for 73.9% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZYDUS HEALTHCARE (USA) LLC | $50.5K | 3 | 33.7% |
| 2 | SSS PHARMACY INC | $16.1K | 1 | 10.7% |
| 3 | NEWLIFE MEDICALS (USA). INC. | $15.6K | 8 | 10.4% |
| 4 | AGRACE PHARMA | $14.7K | 4 | 9.8% |
| 5 | AGRACE PHARMA, | $13.9K | 2 | 9.3% |
| 6 | AMSTERDAM PHARMA (APTEKA RX INC) | $11.0K | 4 | 7.3% |
| 7 | AGRACE PHARMA. | $6.4K | 3 | 4.2% |
| 8 | TEVA PHARMACEUTICALS USA INC | $4.1K | 7 | 2.7% |
| 9 | GREENE-VAN PHARMACY CORP | $3.1K | 1 | 2.1% |
| 10 | ESPEE BIOPHARMA & FINECHEM LLC | $2.7K | 2 | 1.8% |
| 11 | NATIONWIDE MEDICAL SURGICAL | $2.0K | 2 | 1.3% |
| 12 | RUBIN CHEMISTS | $1.8K | 1 | 1.2% |
| 13 | NEWLIFE MEDICALS USA INC | $1.8K | 1 | 1.2% |
| 14 | AMNEAL PHARMACEUTICALS OF LLC | $1.6K | 5 | 1.0% |
| 15 | RAFF & HALL PHARMACY, | $1.1K | 2 | 0.7% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED | $51.6K | 5 | 34.4% |
| 2 | MACLEODS PHARMACEUTICALS LTD | $24.4K | 2 | 16.3% |
| 3 | AUROBINDO PHARMA LTD | $23.8K | 12 | 15.9% |
| 4 | ENCUBE ETHICALS PRIVATE LIMITED | $19.2K | 15 | 12.8% |
| 5 | GLENMARK PHARMACEUTICALS LIMITED | $13.9K | 2 | 9.3% |
| 6 | AUROBINDO PHARMA LIMITED | $6.7K | 10 | 4.4% |
| 7 | ALEMBIC PHARMACEUTICALS LIMITED | $6.0K | 2 | 4.0% |
| 8 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $1.8K | 8 | 1.2% |
| 9 | EXTROVIS PRIVATE LIMITED | $1.4K | 4 | 0.9% |
| 10 | GLENMARK PHARMACEUTICALS LTD | $711 | 1 | 0.5% |
| 11 | CADILA HEALTHCARE LIMITED | $287 | 1 | 0.2% |
| 12 | DR.REDDY'S LABORATORIES LTD | $132 | 1 | 0.1% |
| 13 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $25 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Clindamycin suppliers from UNITED STATES to India include ZYDUS HEALTHCARE (USA) LLC, SSS PHARMACY INC, NEWLIFE MEDICALS (USA). INC.. The leading supplier is ZYDUS HEALTHCARE (USA) LLC with import value of $50.5K USD across 3 shipments. India imported Clindamycin worth $150.0K USD from UNITED STATES in total across 64 shipments.
India imported Clindamycin worth $150.0K USD from UNITED STATES across 64 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Clindamycin sourced from UNITED STATES include ZYDUS LIFESCIENCES LIMITED, MACLEODS PHARMACEUTICALS LTD, AUROBINDO PHARMA LTD. The largest buyer is ZYDUS LIFESCIENCES LIMITED with $51.6K in imports across 5 shipments.
The total value of Clindamycin imports from UNITED STATES to India is $150.0K USD, across 64 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
64 Verified Shipments
15 suppliers, 13 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists